Aggamin Pharmaceuticals, LLC — Form D
Aggamin Pharmaceuticals, LLC of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-04-18. The offering totals $3.7M, of which $3.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-04-18
- Form: D
- Accession: 0001574522-13-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $3.7M
- Amount sold: $3.7M
- Investors: 7
- Date of first sale: 2013-03-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-195212
Issuer
- Name: Aggamin Pharmaceuticals, LLC
- CIK: 0001574522
- Entity type: Limited Liability Company
- Jurisdiction: MASSACHUSETTS
- Incorporated: 2009
- Address: 11 BYRON STREET, BOSTON, MA, 02108
- Phone: 212-568-4614
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| John DT Gerber | Director | Washington, DC |
| Subbian Ananth Karumanchi | Director | Boston, MA |
| Paul Kussie | Director | Boston, MA |
| Vikas P Sukhatme | Director | Boston, MA |
| Ravi Ishwar Thadhani | Director | Boston, MA |
More